Amyris gives “food for thought” with Q2 revenue miss, coupled with entry into speciality ingredients. Poised for big second half?
In California, Amyris reported Q2 reported revenue of $7.8mn, up 2% over 2014 but below consensus estimates of $15.7mn, with inflows of $35.5 million that were up 36% from same period of 2014. The company highlighted in its earnings report that it launched its bio-opioids initiative expected to enable low cost supply of active pharmaceutical […]











